Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Leflunomide is more likely to help treat alopecia areata than cause it.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Long-term high-dose fluconazole can cause reversible hair loss.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Levofloxacin may cause skin discoloration and hair loss as side effects.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A woman developed lupus after taking hydroxyurea for two years.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.